Zefamenib; Zefamenibum; BN-104

Chemical Name:

(2-(6-(2-(4-cyclopropylpyrimidin-5-yl)-4-fluorophenoxy)-1,2,4-triazin-5-yl)-2,7-diazaspiro[3.5]nonan-7-yl)((1S,3aR,6aS)-octahydrocyclopenta[c]pyrrol-1-yl)methanone

SMILES Code: 

[H][C@@]12CCC[C@]1([H])[C@H](NC2)C(=O)N3CCC4(CN(C4)C5=C(OC6=CC=C(F)C=C6C7=CN=CN=C7C8CC8)N=NC=N5)CC3

InChi Code:

1S/C31H35FN8O2/c32-21-6-7-25(23(12-21)24-14-33-17-35-26(24)19-4-5-19)42-29-28(36-18-37-38-29)40-15-31(16-40)8-10-39(11-9-31)30(41)27-22-3-1-2-20(22)13-34-27/h6-7,12,14,17-20,22,27,34H,1-5,8-11,13,15-16H2/t20-,22-,27-/m0/s1

InChi Key:

XDXAYPYOHXUEAM-CLHVYKLBSA-N

Keyword:

2938995-50-5；CAS：2938995-50-5；CAS:2938995-50-5；BN-104；BN104；BN 104；Zefamenib；Zefamenibum

Solubility: 

Storage: Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years)

Description: 

BN-104 (BNM-1192) is a selective meningeal protein inhibitor with oral activity and is also a Menin inhibitor.

Target: Menin-MLL